🇺🇸 FDA
Patent

US 8785414

Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

granted A61KA61K31/7105A61P

Quick answer

US patent 8785414 (Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7105, A61P, A61P37/00, A61P37/02